DK166989A - Farmaceutisk middel til oral administration paa basis af et diphosphonsyrederivat - Google Patents

Farmaceutisk middel til oral administration paa basis af et diphosphonsyrederivat

Info

Publication number
DK166989A
DK166989A DK166989A DK166989A DK166989A DK 166989 A DK166989 A DK 166989A DK 166989 A DK166989 A DK 166989A DK 166989 A DK166989 A DK 166989A DK 166989 A DK166989 A DK 166989A
Authority
DK
Denmark
Prior art keywords
pharmaceutical
oral administration
acid derivative
diphosphonic acid
administration based
Prior art date
Application number
DK166989A
Other languages
English (en)
Other versions
DK166989D0 (da
Inventor
Jean-Pierre Fels
Jean-Claude Gromenil
Bernard Abramovici
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9365083&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK166989(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of DK166989D0 publication Critical patent/DK166989D0/da
Publication of DK166989A publication Critical patent/DK166989A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK166989A 1988-04-07 1989-04-06 Farmaceutisk middel til oral administration paa basis af et diphosphonsyrederivat DK166989A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8804628A FR2629716B1 (fr) 1988-04-07 1988-04-07 Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

Publications (2)

Publication Number Publication Date
DK166989D0 DK166989D0 (da) 1989-04-06
DK166989A true DK166989A (da) 1989-10-08

Family

ID=9365083

Family Applications (1)

Application Number Title Priority Date Filing Date
DK166989A DK166989A (da) 1988-04-07 1989-04-06 Farmaceutisk middel til oral administration paa basis af et diphosphonsyrederivat

Country Status (15)

Country Link
US (1) US4980171A (da)
EP (1) EP0336851B1 (da)
JP (1) JP2602947B2 (da)
KR (1) KR0135420B1 (da)
AU (1) AU618796B2 (da)
CA (1) CA1327009C (da)
DE (1) DE68900994D1 (da)
DK (1) DK166989A (da)
FR (1) FR2629716B1 (da)
IE (1) IE60923B1 (da)
IL (1) IL89868A (da)
NZ (1) NZ228617A (da)
OA (1) OA09415A (da)
PH (1) PH26647A (da)
ZA (1) ZA892557B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0550385A1 (de) * 1991-12-19 1993-07-07 Ciba-Geigy Ag Peroral zu verabreichende pharmazeutische Zusammensetzungen, die Methandiphosphonsäure-Derivate und 18-Krone-6 Ether enthalten
SE501389C2 (sv) * 1992-04-24 1995-01-30 Leiras Oy Farmaceutiskt preparat och förfarande för dess framställning
US6406714B1 (en) 1992-12-02 2002-06-18 Merck & Co., Inc. Dry mix formulation for bisphosphonic acids
FR2703590B1 (fr) * 1993-04-05 1995-06-30 Sanofi Elf Utilisation de derives d'acide bisphosphonique pour la preparation de medicaments destines a favoriser la reparation osseuse .
DK0625355T5 (da) * 1993-05-15 2003-12-01 Roche Diagnostics Gmbh Tablet med forbedret biotilgængelighed indeholdende dichlormethylendiphosphonsyre som virksomt stof
ES2118445T3 (es) * 1993-10-26 1998-09-16 Akzo Nobel Nv Acidos aminoalcano-difosfonicos en blanqueo de pasta papelera.
US20010007863A1 (en) * 1998-06-18 2001-07-12 Merck & Co., Inc. Wet granulation formulation for bisphosphonic acids
TW390813B (en) * 1994-04-29 2000-05-21 Merck & Co Inc Wet granulation formulation for bisphosphonic acids
DE19719680A1 (de) 1997-05-09 1998-11-19 Boehringer Mannheim Gmbh Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6015801A (en) * 1997-07-22 2000-01-18 Merck & Co., Inc. Method for inhibiting bone resorption
US6432932B1 (en) 1997-07-22 2002-08-13 Merck & Co., Inc. Method for inhibiting bone resorption
US5994329A (en) 1997-07-22 1999-11-30 Merck & Co., Inc. Method for inhibiting bone resorption
GB2336311A (en) * 1998-04-15 1999-10-20 Merck & Co Inc Bisphosphonate Dosing Regimen
EP0998933A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
EP0998932A1 (de) 1998-10-09 2000-05-10 Boehringer Mannheim Gmbh Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
CN1372468A (zh) * 1999-06-02 2002-10-02 宝洁公司 羟乙磷酸二钠口服制剂
US7084126B1 (en) * 2000-05-01 2006-08-01 Healthpartners Research Foundation Methods and compositions for enhancing cellular function through protection of tissue components
ES2243457T3 (es) * 2001-01-23 2005-12-01 Gador S.A. Composicion que comprende bifosfonatos para la prevencion y/o tratamiento de trastornos metabolicos de huesos, procedimiento de preparacion de dicha composicion y usos de la misma.
CA2480814A1 (en) * 2002-04-05 2003-10-23 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
US20040138180A1 (en) * 2002-10-03 2004-07-15 Barr Laboratories, Inc. Bisphosphonate composition and process for the preparation thereof
ATE369139T1 (de) 2002-12-20 2007-08-15 Hoffmann La Roche Hochdosierte ibandronat-formulierung
CA2539359A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a bisphosphonate
US20050261250A1 (en) * 2004-05-19 2005-11-24 Merck & Co., Inc., Compositions and methods for inhibiting bone resorption
ES2507552T3 (es) * 2005-10-27 2014-10-15 Nexilis Ag Implante que contiene amino-bisfosfonatos y procedimiento para su producción
US8940320B2 (en) * 2005-10-27 2015-01-27 Thommen Medical Ag Dental implant and production method for said implant
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
JP2011517313A (ja) 2007-12-11 2011-06-02 ビアメト ファーマシューティカルズ，インク． 金属結合部分を標的化部分と組み合わせて使用する金属酵素阻害剤
FR2954320B1 (fr) * 2009-12-17 2012-06-15 Cll Pharma Composition pharmaceutique orale suprabiodisponible contenant un acide biphosphonique ou un de ses sels
FR2975300B1 (fr) * 2011-05-19 2013-06-07 Thierry Breul Composition pharmaceutique a biodisponibilite amelioree
GB201200868D0 (en) 2012-01-19 2012-02-29 Depuy Int Ltd Bone filler composition
EP3689202A1 (en) 2017-08-09 2020-08-05 SharkNinja Operating LLC Cooking device and components thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE2534390C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1,3-Di-aminoalkan-1,1-diphosphonsäuren
DE2534391C2 (de) * 1975-08-01 1983-01-13 Henkel KGaA, 4000 Düsseldorf 1-Hydroxy-3-aminoalkan-1,1-diphosphonsäuren
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
US4330530A (en) * 1980-12-22 1982-05-18 The Procter & Gamble Company Anti-arthritic compositions and method using gold salts and organophosphonates
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
GB2135879B (en) * 1983-03-07 1986-05-21 Ciba Geigy Ag Pharmaceutical preparations with uniform elution properties
US4902679A (en) * 1985-12-13 1990-02-20 Norwich Eaton Pharmaceuticals, Inc. Methods of treating diseases with certain geminal diphosphonates

Also Published As

Publication number Publication date
IE891103L (en) 1989-10-07
NZ228617A (en) 1992-02-25
CA1327009C (en) 1994-02-15
FR2629716B1 (fr) 1991-07-19
IE60923B1 (en) 1994-09-07
EP0336851B1 (fr) 1992-03-18
IL89868A0 (en) 1989-12-15
FR2629716A1 (fr) 1989-10-13
JPH026409A (ja) 1990-01-10
KR890015738A (ko) 1989-11-25
AU3258889A (en) 1989-10-12
DK166989D0 (da) 1989-04-06
ZA892557B (en) 1989-12-27
EP0336851A1 (fr) 1989-10-11
KR0135420B1 (ko) 1998-04-23
PH26647A (en) 1992-09-04
OA09415A (fr) 1992-10-15
AU618796B2 (en) 1992-01-09
JP2602947B2 (ja) 1997-04-23
IL89868A (en) 1993-08-18
DE68900994D1 (de) 1992-04-23
US4980171A (en) 1990-12-25

Similar Documents

Publication Publication Date Title
DK166989D0 (da) Farmaceutisk middel til oral administration paa basis af et diphosphonsyrederivat
NL194781B (nl) Farmaceutisch preparaat voor orale toediening dat een cyclosporine bevat.
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
DK0510404T3 (da) Gastroresistente farmaceutiske formuleringer til oral administration indeholdende galdesyresalte
DK1155695T3 (da) Anvendelse af en 1,3-oxathiolannukleosid-analog til fremstillingen af et lægemiddel til specifik indgivelse
NO166111C (no) Fremgangsmaate for fremstilling av et konfekt- eller farmasiprodukt.
DK215887D0 (da) Farmaceutisk praeparat af omeprazol til oral ind- gift
DK257485D0 (da) Farmaceutiske praeparater til oral indgift
FI871492A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-tiometyyli-substituoitujen 1,4-dihydropyridiinien valmistamiseksi
DK148092A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat til selektiv nedsaettelse af lipidniveauet i blodet
FI881882A (fi) Välineistö hammasproteesin kiinnittämiseksi
DK645788A (da) Anvendelse af ergolinderivater til fremstilling af et farmaceutisk praeparat
NO883500D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk aktivt nitrometan.
DK79889D0 (da) Flerlagsplaster til transdermal laegemiddeladministration
DK0587047T3 (da) Farmaceutisk præparat på gestagenbasis
DK689188A (da) Anvendelse af piperidin-derivater til fremstilling af et farmaceutisk praeparat
DK108989D0 (da) Oralt anvendeligt system til styret frigoerelse af aktive stoffer
ES1000119Y (es) Una tableta farmaceutica para administracion oral
DK651588A (da) Anvendelse af en forbindelse til fremstilling af et farmaceutisk praeparat til behandling af fibromyalgia
DK37589A (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
DK646489D0 (da) Farmaceutisk praeparat til regenerering af leukocytter
DK357388D0 (da) Fremgangsmaade til fremstilling af et piperidinylcyklopentylheptensyrederivat
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
DK50388D0 (da) Anvendelse af en benzo-c-phenanthridin-alkaloidforbindelse til fremstilling af et farmaceutisk middel
FI941696A (fi) Systeemi lääkkeen oraaliseen antoon

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
AHB Application shelved due to non-payment